COSCIENS Biopharma Inc. (CSCIF) stock
CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
$6.49+0.00 (0.00%)
Close on Oct 19, 2026Market cap $24.10MP/E –Yield –
COSCIENS Biopharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
COSCIENS Biopharma's operating cash flow for the twelve months ending Mar 31, 2026 was -$8.77M. For fiscal 2025 it was -$8.47M. The highest annual figure on record is $6.83M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$8.47M | – |
| FY2024 | Dec 31, 2024 | -$14.57M | – |
| FY2023 | Dec 31, 2023 | -$2.58M | -149.4% |
| FY2022 | Dec 31, 2022 | $5.23M | – |
| FY2021 | Dec 31, 2021 | -$8.58M | – |
| FY2020 | Dec 31, 2020 | -$4.13M | – |
| FY2019 | Dec 31, 2019 | -$10.73M | -257.1% |
| FY2018 | Dec 31, 2018 | $6.83M | – |
| FY2017 | Dec 31, 2017 | -$22.91M | – |
| FY2016 | Dec 31, 2016 | -$29.01M | – |
| FY2015 | Dec 31, 2015 | -$33.84M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2026 | Mar 31, 2026 | -$2.18M | – |
| Q4 FY2025 | Dec 31, 2025 | -$1.47M | – |
| Q3 FY2025 | Sep 30, 2025 | -$676.00K | – |
| Q2 FY2025 | Jun 30, 2025 | -$4.45M | – |
| Q1 FY2025 | Mar 31, 2025 | -$1.88M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.00M | – |
| Q3 FY2024 | Sep 30, 2024 | -$7.78M | -5502.1% |
| Q2 FY2024 | Jun 30, 2024 | -$1.39M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.38M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.09M | -107.0% |
| Q3 FY2023 | Sep 30, 2023 | $144.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$813.00K | – |
| Q1 FY2023 | Mar 31, 2023 | -$4.06M | – |
| Q4 FY2022 | Dec 31, 2022 | $15.49M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.95M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.85M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.46M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.41M | -195.8% |
| Q3 FY2021 | Sep 30, 2021 | -$1.49M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.64M | – |
| Q1 FY2021 | Mar 31, 2021 | -$1.05M | – |
| Q4 FY2020 | Dec 31, 2020 | $2.52M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.79M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.41M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.44M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.95M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.60M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.17M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.01M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.68M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.44M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.78M | – |
See a number that looks wrong?